AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2014
Jun 6, 2014
30583_dirs_2014-06-06_7ad110f0-790c-47f9-9503-5789f74c5d59.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-06-04
Reporting Person: FUCHS HENRY J (EVP, Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-06-04 | Common Stock | A | 15600 | — | Acquired | 76550 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-06-04 | Stock option (right to buy) common stock | $63.10 | A | 58400 | Acquired | 2024-06-03 | Common Stock (58400) | Direct |
Footnotes
F1: Restricted stock units granted June 4, 2014. Price not applicable,
F2: Option grants vests 6/48ths on December 4, 2014, and 1/48th on the 4th day of every month thereafter.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19